Allergan Inc. et al. v. Canada (Minister of Health) et al., (2011) 400 F.T.R. 164 (FC)

This document cites

• Eli Lilly Canada Inc. v. Apotex Inc. et al., 2009 FC 320
• Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)
• Eli Lilly Canada Inc. v. Apotex Inc. et al., 2007 FC 455
• Solvay Pharma Inc. et al. v. Apotex Inc. et al., (2008) 323 F.T.R. 1 (FC)
• Aventis Pharma Inc. v. Apotex Inc. et al., (2005) 278 F.T.R. 1 (FC)



See all quotations

• Pfizer Canada Inc. et al. v. Novopharm Ltd. et al., (2009) 352 F.T.R. 35 (FC)
• Bristol-Myers Squibb Co. et al. v. Canada (Attorney General) et al., (2005) 334 N.R. 55 (SCC)
• Goodridge v. Pfizer Canada Inc., [2010] O.T.C. Uned. 1095 (SC)
• Whirlpool Corp. et al. v. Camco Inc. et al., (2000) 263 N.R. 88 (SCC)
• Pfizer Canada Inc. et al. v. Canada (Minister of Health) et al., (2007) 366 N.R. 347 (FCA)
• Laboratoires Servier et al. v. Apotex Inc. et al., (2008) 332 F.T.R. 193 (FC)
• Aventis Pharma Inc. et al. v. Apotex Inc. et al., (2006) 354 N.R. 383 (FCA)
• Merck & Co. et al. v. Apotex Inc. et al., (2010) 381 F.T.R. 162 (FC)
• Free World Trust v. Électro Santé Inc. et al., (2000) 263 N.R. 150 (SCC)
• Pfizer Canada Inc. et al. v. Apotex Inc. et al., 2005 FC 1421
• AB Hassle et al. v. Canada (Minister of National Health and Welfare) et al., (2001) 213 F.T.R. 161 (TD)
• Beloit Canada Ltd. v. Valmet Oy, (1986) 64 N.R. 287 (FCA)
• Sanofi-Aventis Canada Inc. et al. v. Novopharm Ltd. et al., (2007) 366 N.R. 231 (FCA)
• Pfizer Canada Inc. et al. v. Canada (Minister of Health) et al., (2009) 360 F.T.R. 200 (FC)
• Dableh v. Ontario Hydro, (1996) 199 N.R. 57 (FCA)
• Abbott Laboratories Ltd. et al. v. Canada (Minister of Health) et al., 2007 FCA 251
• Aventis Pharma Inc. et al. v. Apotex Inc. et al., 2005 FC 1381
• Janssen-Ortho Inc. et al. v. Novopharm Ltd., 2007 FCA 217
• Sanofi-Aventis Canada Inc. et al. v. Laboratoire Riva Inc. et al., 2008 FC 291
• Merck & Co. et al. v. Canada (Minister of Health) et al., 2010 FC 1042
• AB Hassle et al. v. Genpharm Inc. et al., (2003) 243 F.T.R. 6 (FC)
• Schering-Plough Canada Inc. et al. v. Pharmascience Inc. et al., 2009 FC 1128
• Calgon Carbon Corp. v. North Bay (City) et al., (2005) 344 N.R. 224 (FCA)
• Laboratoires Servier et al. v. Apotex Inc. et al., (2009) 392 N.R. 96 (FCA)
• Pfizer Canada Inc. et al. v. Novopharm Ltd. et al., (2010) 408 N.R. 166 (FCA)
• Shell Oil Co. v. Commissioner of Patents, (1982) 44 N.R. 541 (SCC)
• Sanofi-Aventis Canada Inc. v. ratiopharm Inc. et al., 2010 FC 230
• Novo Nordisk Canada Inc. et al. v. Cobalt Pharmaceuticals Inc. et al., 2010 FC 746
• Apotex Inc. and Novopharm Ltd. v. Wellcome Foundation Ltd., (2002) 296 N.R. 130 (SCC)
• Aventis Pharma Inc. v. Pharmascience, 2006 FCA 229